X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1719) 1719
Publication (174) 174
Book Chapter (11) 11
Dissertation (9) 9
Book Review (8) 8
Web Resource (5) 5
Paper (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cefepime (1580) 1580
humans (754) 754
microbiology (490) 490
pharmacology & pharmacy (471) 471
index medicus (443) 443
infectious diseases (424) 424
male (373) 373
microbial sensitivity tests (363) 363
female (349) 349
ceftazidime (330) 330
antibiotics (322) 322
cephalosporins - pharmacology (289) 289
anti-bacterial agents - pharmacology (252) 252
middle aged (246) 246
cephalosporins - therapeutic use (222) 222
aged (219) 219
cephalosporins (218) 218
adult (215) 215
meropenem (213) 213
anti-bacterial agents - therapeutic use (206) 206
pharmacokinetics (189) 189
infections (186) 186
drug resistance (152) 152
resistance (147) 147
imipenem (140) 140
therapy (132) 132
bacteria (128) 128
cephalosporins - administration & dosage (126) 126
amikacin (124) 124
anti-bacterial agents - administration & dosage (124) 124
piperacillin-tazobactam (124) 124
antimicrobial agents (122) 122
cephalosporins - pharmacokinetics (122) 122
ciprofloxacin (122) 122
piperacillin (122) 122
tazobactam (122) 122
cefotaxime (120) 120
cephalosporins - adverse effects (120) 120
ceftriaxone (119) 119
escherichia-coli (119) 119
adolescent (111) 111
treatment outcome (111) 111
animals (110) 110
pseudomonas aeruginosa - drug effects (109) 109
hospitals (106) 106
enterobacteriaceae (103) 103
aged, 80 and over (102) 102
bacteremia (97) 97
mortality (97) 97
epidemiology (96) 96
oncology (96) 96
vancomycin (96) 96
pseudomonas-aeruginosa (93) 93
retrospective studies (92) 92
pseudomonas aeruginosa (91) 91
research article (90) 90
klebsiella-pneumoniae (87) 87
anti-bacterial agents - pharmacokinetics (86) 86
infection (86) 86
carbapenems (85) 85
cefpirome (83) 83
pharmacodynamics (83) 83
pneumonia (83) 83
anti-bacterial agents - adverse effects (82) 82
beta-lactamases - metabolism (82) 82
gram-negative bacteria (82) 82
biochemical phenomena, metabolism, and nutrition (81) 81
cephalosporin (81) 81
health aspects (81) 81
pathogens (81) 81
polycyclic compounds (81) 81
penicillanic acid - analogs & derivatives (80) 80
child (79) 79
susceptibility (76) 76
beta-lactam antibiotics (75) 75
patients (75) 75
pediatrics (75) 75
analysis (74) 74
prospective studies (74) 74
bacterial infections and mycoses (73) 73
enterobacteriaceae - drug effects (73) 73
febrile neutropenia (73) 73
risk factors (72) 72
e coli (70) 70
fever (70) 70
gentamicin (70) 70
gram-negative bacteria - drug effects (70) 70
immunology (70) 70
internal medicine (69) 69
beta-lactamases - genetics (68) 68
bacteria - drug effects (67) 67
ceftazidime - pharmacology (67) 67
children (67) 67
neutropenia (67) 67
escherichia coli - drug effects (66) 66
antimicrobial resistance (65) 65
bacterial infections - drug therapy (65) 65
medicine & public health (65) 65
chemistry, analytical (64) 64
drug resistance, microbial (64) 64
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1611) 1611
French (47) 47
Chinese (19) 19
Spanish (17) 17
Japanese (14) 14
Korean (9) 9
Portuguese (7) 7
Turkish (7) 7
German (6) 6
Croatian (2) 2
Polish (2) 2
Slovak (2) 2
Italian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
03/2014
There is an increase in isolation of extended spectrum beta-lactamase (ESBL) producing isolates from clinical samples worldwide. In developing countries the... 
Klebsiella pneumonia | susceptibility | Escherichia coli | Tanzania | cefepime
Web Resource
07/2010
Aims : In this study in cirrhosis patients having spontaneous ascites infection (SAI) the investigation of the activity of cefepime being a fourth generation... 
cefepime | cirrhosis | Spontaneous ascites infection
Web Resource
08/2007
Pharmacokinetics of cefepimewas studied after single dose intravenous administration at the dose rate of 5 mg/kg body weight in calves. Blood samples were... 
Cefepime, Calves, Pharmacokinetics, Intravenous
Web Resource
Respirology, ISSN 1323-7799, 11/2018, Volume 23, Issue S2, pp. 193 - 193
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 08/2019, Volume 69, Issue 3, pp. 534 - 537
A cluster of cefepime-induced neutropenia (CIN) was identified from June 2017 to May 2018 in a regional outpatient parenteral antimicrobial therapy population.... 
OPAT | INFECTIOUS DISEASES | drug-induced neutropenia | cefepime | adverse drug event | MICROBIOLOGY | cefepime-induced neutropenia | BOLUS | IMMUNOLOGY
Journal Article
American Journal of Infection Control, ISSN 0196-6553, 2019
Background: Antimicrobial use (AU) of antipseudomonal β-lactams (APBL) has significantly increased over the past decade in US hospitals. This retrospective... 
SAAR | Meropenem | Antibiotics | Cefepime | Bacteremia | Peritonitis
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2017, Volume 61, Issue 9
Journal Article
Epilepsy Research, ISSN 0920-1211, 11/2019, Volume 157, p. 106195
The antibiotics cefepime and meropenem are recommended for the treatment of neutropenia. However, cefepime has been found to be associated with both peripheral... 
Meropenem | Cefepime | 5-Fluorouracil | Convulsions | Kindling | Convulsive status
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 11/2018, Volume 52, Issue 5, pp. 719 - 723
Journal Article
International journal of antimicrobial agents, ISSN 0924-8579, 07/2019
Enterobacter spp. are a common cause of nosocomial pneumonia and treatment can be complicated by AmpC resistance. Carbapenems are the treatment of choice;... 
Journal Article
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2018, Volume 396, pp. 33 - 35
Highlights•Opsoclonus might be associated with cefepime neurotoxicity. •Cefepime neurotoxicity most commonly presents with myoclonus and encephalopathy.... 
Neurology | Opsoclonus | Neurotoxicity | Cefepime | Myoclonus | Encephalopathy | NEUROSCIENCES | CLINICAL NEUROLOGY
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 07/2017, Volume 65, Issue 1, pp. 178 - 179
Journal Article
01/2012
Purpose: Extended spectrum β-lactamase (ESBL) and AmpC β-lactamase are important mechanisms of betalactam resistance among Enterobacteriaceae . The ESBL... 
boronic acid | Extended spectrum β-lactamase | cefepime | AmpC β-lactamase | Enterobacteriaceae
Web Resource
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2018, Volume 62, Issue 8
WCK 5222 is a combination of cefepime and the novel β-lactam enhancer zidebactam being developed for the treatment of serious Gram-negative bacterial... 
Epithelial lining fluid | WCK 5222 | Zidebactam | Cefepime | Pharmacokinetics | Alveolar macrophages
Journal Article
CRITICAL CARE, ISSN 1466-609X, 04/2019, Volume 23, Issue 1, p. 147
[...]median days of use of cefipime was 4.5 days in this study which suggest that physicians might have stopped the drug because of delirium as it is known... 
Delirium | DEXMEDETOMIDINE | Cefepime | Antibiotics | SEDATION | CRITICAL CARE MEDICINE | Studies | Neurotoxicity | Critical care | Anesthesia | Systematic review
Journal Article
Indian Veterinary Journal, ISSN 0019-6479, 01/2017, Volume 94, Issue 1, pp. 53 - 54
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.